• Explore /
  • Poster
  • / Phase 1/2 study of forodesine in patients with relapsed peripheral t-cell lymphoma (PTCL).

Phase 1/2 study of forodesine in patients with relapsed peripheral t-cell lymphoma (PTCL).

Abstract Poster

Authors

null

Kunihiro Tsukasaki

National Cancer Center Hospital East, Kashiwa, Japan

Kunihiro Tsukasaki , Kensei Tobinai , Toshiki Uchida , Yoshinobu Maeda , Hirohiko Shibayama , Hirokazu Nagai , Mitsutoshi Kurosawa , Yasunobu Abe , Kiyohiko Hatake , Kiyoshi Ando , Isao Yoshida , Michihiro Hidaka , Tohru Murayama , Yoko Okitsu , Norifumi Tsukamoto , Masafumi Taniwaki , Junji Suzumiya , Kazuo Tamura , Takahiro Yamauchi , Ryuzo Ueda

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Non-Hodgkin Lymphoma

Clinical Trial Registration Number

NCT01776411

Citation

J Clin Oncol 34, 2016 (suppl; abstr 7542)

DOI

10.1200/JCO.2016.34.15_suppl.7542

Abstract #

7542

Poster Bd #

98

Abstract Disclosures

Similar Posters

First Author: Joanna S. Yi

First Author: Neha Mehta-Shah

First Author: Jonathan W. Goldman

First Author: Kim Anna Reiss